APA (7th ed.) Citation

Senguttuvan, R. N., Wei, C., Raoof, M., Dellinger, T. H., & Wang, E. W. (2023). Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma. Journal of Clinical Medicine, 12(11), 3839. https://doi.org/10.3390/jcm12113839

Chicago Style (17th ed.) Citation

Senguttuvan, Rosemary Noel, Christina Wei, Mustafa Raoof, Thanh H. Dellinger, and Edward Wenge Wang. "Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma." Journal of Clinical Medicine 12, no. 11 (2023): 3839. https://doi.org/10.3390/jcm12113839.

MLA (9th ed.) Citation

Senguttuvan, Rosemary Noel, et al. "Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma." Journal of Clinical Medicine, vol. 12, no. 11, 2023, p. 3839, https://doi.org/10.3390/jcm12113839.